Normothermic machine perfusion market to hit $3.12 billion by 2030

The normothermic machine perfusion market is forecast to grow from $1.48 billion in 2025 to $3.12 billion by 2030, powered by rising transplant demand and faster preservation technology. North America held the largest share in 2025 as the market expands across major regions.

Why it matters: - Normothermic machine perfusion is becoming more important as transplant demand rises and organ preservation methods improve. - The technology can keep donor organs viable at body temperature longer, which may improve transplant readiness and outcomes. - The market’s projected growth signals stronger investment and innovation in organ preservation tools.

What happened: - The Business Research Company published its Normothermic Machine Perfusion Global Market Report 2026, covering market size, trends and a forecast through 2035. - The market was valued at $1.48 billion in 2025 and is projected to reach $1.72 billion in 2026. - The report forecasts the market will reach $3.12 billion by 2030. - The report identifies North America as the largest regional market in 2025. - The report also covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - A free sample of the report is available here. - The full report is available here.

The details: - Normothermic machine perfusion preserves organs at about 37°C while supplying oxygenated blood or perfusate. - The process mimics natural physiological conditions during storage before transplantation. - The technique can extend preservation times and allow functional assessment of organs before transplant. - The report ties near-term growth to continued reliance on traditional cold storage, limited preservation options, organ shortages, rising transplant procedures and early stationary perfusion devices. - Longer-term growth is linked to portable and battery-powered machines, better mechanical circulation and oxygenation, smart monitoring systems and more R&D in organ preservation. - The report says the market grew at a 16.2% CAGR from 2025 to 2026 and is expected to grow at a 16.0% CAGR through 2030. - The U.S. Department of Health & Human Services reported 46,632 organ transplants in 2023, up 8.7% from 2022.

Between the lines: - The market forecast reflects a broader shift from organ storage to active preservation and real-time assessment. - Portable and battery-powered systems suggest a move toward more flexible use in clinical settings and transport. - Smart monitoring and improved circulation tools point to a market that is becoming more data-driven and technically integrated.

What's next: - Growth will likely track transplant volumes, preservation technology upgrades and adoption of newer perfusion systems. - The report’s regional coverage suggests competition and adoption will remain global rather than concentrated in one market. - Additional analytical tools in the 2026 report include market attractiveness scoring, TAM analysis, company scoring matrices, forecasting dashboards, hotspots infographics and updated graphics and tables.